Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-β1 in thyroid hormone-induced cardiac hypertrophy

Pflugers Archiv European Journal of Physiology

Volumn 454, Issue 1, 2007, Pages 75-81

  Diniz, G P ^a   Carneiro Ramos, M S ^a   Barreto Chaves, M L M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II receptors; Cardiac hypertrophy; Renin angiotensin system; TGF 1; Thyroid hormone

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; LIOTHYRONINE; LOSARTAN; THYROID HORMONE; THYROXINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GOITER; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERTHYROIDISM; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 33847651830     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-006-0192-0     Document Type: Article

References (33)

1. Bassett JH, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213:1-11
2. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG (1994) Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75:23-32
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
4. Brand T, Schneider MD (1995) Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription. J Biol Chem 270:8274-8284
5. Carneiro-Ramos MS, Silva VB, Santos RA, Barreto-Chaves ML (2006) Tissue-specific modulation of angiotensin-converting enzyme (ACE) in hyperthyroidism. Peptides 27:2942-2949
6. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 35:569-582
7. Giannocco G, DosSantos RA, Nunes MT (2004) Thyroid hormone stimulates myoglobin gene expression in rat cardiac muscle. Mol Cell Endocrinol 226:19-26
8. Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML (2003) Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285:R1473-R1480
9. Irvine SA, Foka P, Rogers SA, Mead JR, Ramji DP (2005) A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res 33:1423-1434
10. Klein I (1988) Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 123:203-210
11. Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T (1999) Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol 160:43-47
12. Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874-881
13. Liang F, Webb P, Marimuthu A, Zhang S, Gardner DG (2003) Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 278:15073-15083
14. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA (1997) Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 99:1926-1935
15. Morgan HE, Baker KM (1991) Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 83:13-25
16. Nakajima H, Nakajima HO, Salcher O, Dittie AS, Dembowsky K, Jing S, Field LJ (2000) Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res 86:571-579
17. Prada P, Okamoto MM, Furukawa LN, Machado UF, Heimann JC, Dolnikoff MS (2000) High- or low-salt diet from weaning to adulthood: effect on insulin sensitivity in Wistar rats. Hypertension 35:424-429
18. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M (2005) TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol 203:345-352
19. Rosenkranz S (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423-432
20. Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schluter KD, Bohm M (2002) Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol, Heart Circ Physiol 283:H1253-H1262
21. Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73:413-423
22. Sanford CF, Griffin EE, Wildenthal K (1978) Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats. Circ Res 43:688-694
23. Schnee JM, Hsueh WA (2000) Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 46:264-268
24. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T (2002) TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109:787-796
25. Scott L, Kerr A, Haydock D, Merrilees M (1997) Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlate with susceptibility to atherosclerosis. J Vasc Res 34:365-377
26. Sernia C, Marchant C, Brown L, Hoey A (1993) Cardiac angiotensin receptors in experimental hyperthyroidism in dogs. Cardiovasc Res 27:423-428
27. Siehl D, Chua BH, Lautensack-Belser N, Morgan HE (1985) Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart. Am J Physiol 248:C309-C319
28. Soufla G, Porichis F, Sourvinos G, Vassilaros S, Spandidos DA (2006) Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett 235:100-113
29. van Wamel AJ, Ruwhof C, van der Valk-Kokshoorn LJ, Schrier PI, van der Laarse A (2002) Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes. Mol Cell Biochem 236:147-153
30. Wada H, Zile MR, Ivester CT, Cooper Gt, McDermott PJ (1996) Comparative effects of contraction and angiotensin II on growth of adult feline cardiocytes in primary culture. Am J Physiol 271:H29-H37
31. Wenzel S, Schorr K, Degenhardt H, Frischkopf K, Kojda G, Wiesner RJ, Rosenkranz S, Piper HM, Schluter KD (2001) TGF-beta(1) downregulates PTHrP in coronary endothelial cells. J Mol Cell Cardiol 33:1181-1190
32. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr (1977) Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 252:2787-2789
33. Zhang X, Yang J, Li Y, Liu Y (2005) Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol 288:F16-F26